# Fulgent Genetics, Inc. (FLGT) MD&A by fiscal year

Verbatim Item 7 Management's Discussion and Analysis sections from Fulgent Genetics, Inc.'s 10-K filings, one page per fiscal year. Extracted from SEC filings with the same bounded parser for every year. Filer text, not grepcent analysis or investment advice.

- [FY 2025 MD&A](/company/FLGT/mda/fy2025/): filed 2026-02-27; accession 0001193125-26-079169 (https://www.sec.gov/Archives/edgar/data/1674930/000119312526079169/flgt-20251231.htm); latest 10-K
- [FY 2024 MD&A](/company/FLGT/mda/fy2024/): filed 2025-02-28; accession 0000950170-25-029512 (https://www.sec.gov/Archives/edgar/data/1674930/000095017025029512/flgt-20241231.htm)
- [FY 2023 MD&A](/company/FLGT/mda/fy2023/): filed 2024-02-28; accession 0000950170-24-022233 (https://www.sec.gov/Archives/edgar/data/1674930/000095017024022233/flgt-20231231.htm)
- [FY 2022 MD&A](/company/FLGT/mda/fy2022/): filed 2023-02-28; accession 0000950170-23-005178 (https://www.sec.gov/Archives/edgar/data/1674930/000095017023005178/flgt-20221231.htm)
- [FY 2021 MD&A](/company/FLGT/mda/fy2021/): filed 2022-02-28; accession 0001564590-22-007366 (https://www.sec.gov/Archives/edgar/data/1674930/000156459022007366/flgt-10k_20211231.htm)

Back to /company/FLGT/